FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/01/2025
Voltar para busca
Dado oficial do USPTO
COLLINK.3D
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
25/01/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
27/03/2022
Data de registro
23/07/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/07/2024
Última transação
25/01/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
IL
Examinador
YOUNG, THOMAS
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
CollPlant Ltd.
Representantes
Jeffrey A. Smith Millen, White, Zelano & Branigan, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in pharmaceuticalmedicalcosmeticsveterinary and aesthetic industries; chemicals for use in organ transplantationchemicals for the manufacture of 3D printed scaffoldstissues and organsnot for medical purposes; bio-chemicals for use in pharmaceuticalmedicalcosmeticsveterinary and aesthetic industries; bio-chemicals for use in organ transplantationbio-chemicals for the manufacture of 3D printed scaffoldstissues and organsnot for medical purposes; biological preparations for use in industry and scienceother than for medicalveterinarycosmetics or aesthetic use; biological preparations for use in cosmetics and aesthetic industry; biological preparations for use in industrybio-printable materials in the nature of cells and bio-inks being bio-chemicals for use in cosmetics and aesthetic industriesnot for medical use or veterinary purposes; biological preparations for use in cell cultures for applications in the field of cosmeticsnot for medical or veterinary use
Classe 5
Biological preparations for use in pharmaceuticalmedical and veterinary industryfor personalized medicine use in the nature of treatment of autoimmune diseases and disorderscardiovascular diseases and disordersmetabolic diseases and disordersmicrobial disorders and diseasesfungal disorders and diseasesinflammatory disorders and diseasesvaginal and rectal disorders and diseasesear and eye disordersorthopedic diseases and disorderscentral and peripheral nervous system diseases and disordersendocrine system diseases and disordersneurodegenerative diseases and disordersnasal pharyngeal diseases and disordercancerinfectious diseases and viral infections; bioadhesivesmedical adhesives intended for closure of wounds and gaps and for other medical fixingbinding internal tissue; bio-printed materials for use in organ transplantationbiological softhardskin and bone tissue grafts and culturesimplantable scaffolds comprised of living tissue or cellsorgan implants comprised of living tissue or cellsintended for subsequent implantationbio-inks comprised of living cells which stimulates tissue regeneration and support cell adherence and proliferation for medical use; biological implantsbiological soft and hard human connective tissue intended for subsequent implantation and organ implants comprised of living tissue or cellsintended for subsequent implantation; biological preparations for use in cell culture applications in the fields of pharmaceuticalmedicalveterinary and aesthetic medicine usecell culture media for cultivating animal or human tissue or cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/01/2025
FIMP
FINAL DISPOSITION PROCESSED
04/01/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
23/07/2024
GPNX
NOTIFICATION PROCESSED BY IB
07/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/05/2024
PUBO
PUBLISHED FOR OPPOSITION
07/05/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/04/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
13/03/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/03/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
13/03/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/03/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
13/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/01/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
24/01/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
13/09/2023
GNFR
FINAL REFUSAL E-MAILED
13/09/2023
CNFR
FINAL REFUSAL WRITTEN
13/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2023
RFNT
REFUSAL PROCESSED BY IB
29/03/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/03/2023
RFRR
REFUSAL PROCESSED BY MPU
08/03/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/01/2023
CNRT
NON-FINAL ACTION WRITTEN
11/01/2023
DOCK
ASSIGNED TO EXAMINER
11/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
23/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/08/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/08/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace COLLINK.3D ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.